Polyclonal Serum Free Light Chains: A Biomarker of Disease Prognosis or of Immune Senescence? Reply

被引：0
|
作者：
Pardanani, Animesh [1 ]
Tefferi, Ayalew [1 ]
机构：
[1] Mayo Clin, Rochester, MN 55905 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 24期
关键词：
D O I：
10.1200/JCO.2012.44.3176
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3034 / 3034
页数：1
相关论文
共 50 条
  • [31] Free light chains a novel biomarker of cardiovascular disease. A pilot study
    Basile, U.
    La Rosa, G.
    Napodano, C.
    Pocino, K.
    Cappannoli, L.
    Gulli, F.
    Cianfrocca, C.
    Di Stasio, E.
    Biasucci, L. M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (06) : 2563 - 2569
  • [32] Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?
    Hutchison, Colin A.
    Cockwell, Paul
    Harding, Steven
    Mead, Graham P.
    Bradwell, Arthur R.
    Barnett, Anthony H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (06) : 667 - 676
  • [33] Quantitation of Serum Free Light Chains
    Bakker, Andries J.
    Bierma-Ram, Ageeth
    Elderman-van der Werf, Coby
    Strijdhaftig, Marcia L.
    van Zanden, Jelmer J.
    CLINICAL CHEMISTRY, 2009, 55 (08) : 1585 - 1587
  • [34] ABNORMALLY ELEVATED SERUM FREE LIGHT CHAINS IN PATIENTS WITH LIVER DISEASE
    Assi, L. K.
    Hughes, R. G.
    Gunson, B.
    Webb, G. M.
    Drayson, M. T.
    Bradwell, A. R.
    Adams, D. H.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S440 - S441
  • [35] Cell Population Data and Serum Polyclonal Immunoglobulin Free Light Chains in the Assessment of COVID-19 Severity
    Malecka-Gieldowska, Milena
    Folta, Maria
    Wisniewska, Agnieszka
    Czyzewska, Emilia
    Ciepiela, Olga
    VIRUSES-BASEL, 2021, 13 (07):
  • [36] Cell population data and serum polyclonal immunoglobulin free light chains in the assessment of COVID-19 severity
    Gieldowska, Milena Malecka
    Gieldowska, Milena Malecka
    Ciepiela, Olga
    Ciepiela, Olga
    Wisniewska, Agnieszka
    Wisniewska, Agnieszka
    Czyzewska, Emilia
    Czyzewska, Emilia
    Folta, Maria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 191 - 191
  • [37] Impact of chronic renal failure and hemodialysis on serum free polyclonal immunoglobulin kappa/lambda light-chains
    Scherberich, Juergen
    Hammer, Florentine
    Rolinski, Boris
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 22 - 22
  • [38] Polyclonal Serum Free Light Chains Levels Are Associated with Carotid Atherosclerosis in Subjects with Type 2 Diabetes Mellitus
    Aberer, Felix
    Tripolt, Norbert J.
    Eder, Michaela
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Sourij, Harald
    DIABETES, 2017, 66 : A117 - A117
  • [39] Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease
    Liguori, Antonio
    D'Ambrosio, Francesca
    Napodano, Cecilia
    Gentili, Vanessa
    Giustiniani, Maria Cristina
    Pompili, Maurizio
    Grieco, Antonio
    Rapaccini, Gianludovico
    Urbani, Andrea
    Gasbarrini, Antonio
    Basile, Umberto
    Miele, Luca
    LIVER INTERNATIONAL, 2024, 44 (10) : 2625 - 2638
  • [40] POLYCLONAL FREE LIGHT CHAINS AS A PREDICTOR OF CKD PROGRESSION IN NONPROLIFERATIVE GLOMERULOPATHIES
    Churko, Anna
    Khrabrova, Maria
    Smirnov, Alexei
    Sipovski, Vassili
    Panina, Iraida
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345